The American Heart Association will honor Dr. Annet Kirabo, D.V.M., Ph.D., FAHA, with the 2026 Joseph A. Vita Award at its Scientific Sessions 2026, to be held Nov. 6-9 in Chicago. The award recognizes a scientist whose research has significantly advanced cardiovascular biology or health within the past five years and whose work has been published in the Association's journals. Dr. Kirabo, a professor of medicine at Vanderbilt Health, will receive the award during the Opening Session on Saturday, Nov. 7. The recognition matters because it signals a fundamental shift in how scientists understand hypertension, moving beyond traditional models to embrace the immune system as a central driver of cardiovascular disease.
Dr. Kirabo's pioneering research revealed that lipid oxidation-derived protein adducts act as neoantigens, triggering antigen-presenting cell activation, T-cell responses, vascular dysfunction, and ultimately hypertension. These findings, detailed in studies such as those referenced by the lipid oxidation-derived protein adducts research, fundamentally changed the scientific understanding of blood pressure regulation. Her laboratory now combines immunology, vascular biology, genomics, metabolomics, and single-cell technologies to identify new therapeutic strategies for cardiovascular and kidney disease. This work has opened exciting possibilities for preventing and treating hypertension, a condition affecting millions worldwide.
The implications extend far beyond the laboratory. By uncovering potential therapeutic targets like isolevuglandins and sodium-sensing pathways in immune cells, Dr. Kirabo's discoveries offer new hope for patients with resistant hypertension and related cardiovascular and kidney diseases. Her sustained NIH funding and more than 230 scientific publications have established new directions in cardiovascular science, influencing investigators globally. The award, named after the late Joseph A. Vita, M.D., founding editor of the Journal of the American Heart Association, celebrates research that transforms cardiovascular science. Dr. Kirabo's work epitomizes this mission, as noted by Manesh R. Patel, M.D., FAHA, the Association's 2026-2027 volunteer president, who called her discoveries a paradigm shift.
Beyond her research, Dr. Kirabo has been an active Heart Association volunteer since 2009, serving on the Council on Hypertension Communications Committee and the Council Operations Committee. She has been on the editorial board of the Hypertension journal since 2018 and an associate editor of Circulation Research since 2019. Her dedication to mentorship has trained dozens of early-career investigators, many of whom now lead independent research programs. This commitment ensures that the momentum she has built in cardiovascular science will continue for years to come.
The award will be presented at Scientific Sessions 2026, a premier global exchange of cardiovascular science. Additional multimedia is available on the right column of the release link. For more news, follow the Association on X @HeartNews. The recognition of Dr. Kirabo underscores the growing importance of immunology in cardiovascular medicine and highlights how targeting inflammation could revolutionize hypertension treatment, potentially reducing the global burden of heart disease and stroke. As the field moves toward precision medicine, her work provides a roadmap for translating mechanistic insights into life-saving therapies.
